1. Home
  2. BMR vs ATOS Comparison

BMR vs ATOS Comparison

Compare BMR & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beamr Imaging Ltd.

BMR

Beamr Imaging Ltd.

HOLD

Current Price

$1.38

Market Cap

24.5M

Sector

Technology

ML Signal

HOLD

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

HOLD

Current Price

$2.62

Market Cap

24.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMR
ATOS
Founded
2009
2009
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.5M
24.4M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
BMR
ATOS
Price
$1.38
$2.62
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $19.00
AVG Volume (30 Days)
63.7K
★ 96.2K
Earning Date
08-11-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,758.00
Revenue This Year
$0.19
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.06
$0.53
52 Week High
$2.88
$7.56

Technical Indicators

Market Signals
Indicator
BMR
ATOS
Relative Strength Index (RSI) 44.14 55.41
Support Level $1.19 $2.32
Resistance Level $1.40 $3.04
Average True Range (ATR) 0.14 0.28
MACD -0.03 0.02
Stochastic Oscillator 3.70 52.50

Price Performance

Historical Comparison
BMR
ATOS

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd provides content-adaptive video compression solutions for human viewing and machine vision. The company is trusted by technology companies such as NVIDIA and Amazon Web Services, and serves media companies including Netflix, Paramount, and JioHotstar. Using Emmy-winning patented technology, its solutions help deliver media content with high quality while reducing storage and delivery costs. Its customers include over-the-top content distributors, video streaming platforms, and Hollywood studios that use its products to store, distribute, and monetize video and images across devices. The company operates in the United States, Israel, and the rest of the world, with the United States generating maximum revenue.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.

Share on Social Networks: